Financing Proceeds to Accelerate Growth and Market Expansion in Leading Digital PCR and Next-Gen Sequencing Products BILLERICA, Mass.-RainDance Technologies, Inc., an innovative genomics tools company enabling ultra-sensitive detection of cancer and inherited diseases, today announced
RainDance RainDrop™ Technology and the Use of IDT PrimeTime® qPCR Assays Author: Ellen Prediger, PhD, is the Director of Scientific Communication at IDT. Digital technology has made its way into PCR, allowing researchers to perform absolute quantification of a target sequence by simp
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.